CN102146414B - 玫瑰孢链霉菌基因工程菌的构建方法及其应用 - Google Patents
玫瑰孢链霉菌基因工程菌的构建方法及其应用 Download PDFInfo
- Publication number
- CN102146414B CN102146414B CN 201010236729 CN201010236729A CN102146414B CN 102146414 B CN102146414 B CN 102146414B CN 201010236729 CN201010236729 CN 201010236729 CN 201010236729 A CN201010236729 A CN 201010236729A CN 102146414 B CN102146414 B CN 102146414B
- Authority
- CN
- China
- Prior art keywords
- daptomycin
- gene
- streptomyces
- streptomyces roseosporus
- genetic engineering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000894006 Bacteria Species 0.000 title claims abstract description 41
- 241000958215 Streptomyces filamentosus Species 0.000 title claims abstract description 27
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 19
- 238000010276 construction Methods 0.000 title claims abstract description 16
- DOAKLVKFURWEDJ-QCMAZARJSA-N daptomycin Chemical compound C([C@H]1C(=O)O[C@H](C)[C@@H](C(NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@H](C(=O)N1)[C@H](C)CC(O)=O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)CCCCCCCCC)C(=O)C1=CC=CC=C1N DOAKLVKFURWEDJ-QCMAZARJSA-N 0.000 claims abstract description 44
- 108010013198 Daptomycin Proteins 0.000 claims abstract description 43
- 229960005484 daptomycin Drugs 0.000 claims abstract description 43
- 238000000034 method Methods 0.000 claims abstract description 28
- 239000013604 expression vector Substances 0.000 claims abstract description 15
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 12
- 239000013612 plasmid Substances 0.000 claims abstract description 9
- 238000012546 transfer Methods 0.000 claims abstract description 7
- 238000010353 genetic engineering Methods 0.000 claims description 21
- 230000008569 process Effects 0.000 claims description 18
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 238000004321 preservation Methods 0.000 claims description 10
- 101000979117 Curvularia clavata Nonribosomal peptide synthetase Proteins 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- 238000000855 fermentation Methods 0.000 claims description 8
- 230000004151 fermentation Effects 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- MHWLWQUZZRMNGJ-UHFFFAOYSA-N nalidixic acid Chemical class C1=C(C)N=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 MHWLWQUZZRMNGJ-UHFFFAOYSA-N 0.000 claims description 8
- 239000000725 suspension Substances 0.000 claims description 8
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 claims description 6
- 230000000968 intestinal effect Effects 0.000 claims description 6
- 101150044508 key gene Proteins 0.000 claims description 6
- 238000003259 recombinant expression Methods 0.000 claims description 6
- 238000012216 screening Methods 0.000 claims description 6
- 101150109417 NRPS gene Proteins 0.000 claims description 5
- 238000013461 design Methods 0.000 claims description 5
- 244000005700 microbiome Species 0.000 claims description 5
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 4
- 241000187747 Streptomyces Species 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 239000002054 inoculum Substances 0.000 claims description 4
- QYDYPVFESGNLHU-KHPPLWFESA-N methyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC QYDYPVFESGNLHU-KHPPLWFESA-N 0.000 claims description 4
- 229940071229 oxygen 45 % Drugs 0.000 claims description 4
- 239000011148 porous material Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 238000011218 seed culture Methods 0.000 claims description 4
- 239000013598 vector Substances 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 3
- 230000008676 import Effects 0.000 claims description 3
- 235000003276 Apios tuberosa Nutrition 0.000 claims description 2
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 2
- 235000010744 Arachis villosulicarpa Nutrition 0.000 claims description 2
- 244000133018 Panax trifolius Species 0.000 claims description 2
- 230000003321 amplification Effects 0.000 claims description 2
- 229960001230 asparagine Drugs 0.000 claims description 2
- 239000005018 casein Substances 0.000 claims description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 2
- 235000021240 caseins Nutrition 0.000 claims description 2
- 235000013305 food Nutrition 0.000 claims description 2
- 235000012054 meals Nutrition 0.000 claims description 2
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 2
- 239000013600 plasmid vector Substances 0.000 claims description 2
- 241000588724 Escherichia coli Species 0.000 abstract description 5
- 238000012790 confirmation Methods 0.000 abstract description 3
- 108091008053 gene clusters Proteins 0.000 abstract description 2
- 108010019477 S-adenosyl-L-methionine-dependent N-methyltransferase Proteins 0.000 abstract 2
- 108010000785 non-ribosomal peptide synthase Proteins 0.000 abstract 2
- 238000003752 polymerase chain reaction Methods 0.000 abstract 2
- 241000588722 Escherichia Species 0.000 abstract 1
- 238000010367 cloning Methods 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- XZNUGFQTQHRASN-XQENGBIVSA-N apramycin Chemical compound O([C@H]1O[C@@H]2[C@H](O)[C@@H]([C@H](O[C@H]2C[C@H]1N)O[C@@H]1[C@@H]([C@@H](O)[C@H](N)[C@@H](CO)O1)O)NC)[C@@H]1[C@@H](N)C[C@@H](N)[C@H](O)[C@H]1O XZNUGFQTQHRASN-XQENGBIVSA-N 0.000 description 10
- 229950006334 apramycin Drugs 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 229960000210 nalidixic acid Drugs 0.000 description 7
- 230000035939 shock Effects 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000004913 activation Effects 0.000 description 4
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 229940049547 paraxin Drugs 0.000 description 4
- 102000003960 Ligases Human genes 0.000 description 3
- 108090000364 Ligases Proteins 0.000 description 3
- 238000006555 catalytic reaction Methods 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 210000003705 ribosome Anatomy 0.000 description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- 241001655322 Streptomycetales Species 0.000 description 2
- 108700005078 Synthetic Genes Proteins 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- 239000006035 Tryptophane Substances 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000006916 nutrient agar Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 229960004799 tryptophan Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical class NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 description 1
- 101710146995 Acyl carrier protein Proteins 0.000 description 1
- 102000016680 Dioxygenases Human genes 0.000 description 1
- 108010028143 Dioxygenases Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960001570 ademetionine Drugs 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000003570 biosynthesizing effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000022888 negative regulation of membrane potential Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 108090000765 processed proteins & peptides Chemical class 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000000192 social effect Effects 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010236729 CN102146414B (zh) | 2010-07-26 | 2010-07-26 | 玫瑰孢链霉菌基因工程菌的构建方法及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010236729 CN102146414B (zh) | 2010-07-26 | 2010-07-26 | 玫瑰孢链霉菌基因工程菌的构建方法及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102146414A CN102146414A (zh) | 2011-08-10 |
CN102146414B true CN102146414B (zh) | 2012-12-12 |
Family
ID=44420885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201010236729 Expired - Fee Related CN102146414B (zh) | 2010-07-26 | 2010-07-26 | 玫瑰孢链霉菌基因工程菌的构建方法及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102146414B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102965304B (zh) * | 2011-10-27 | 2014-03-26 | 四川大学 | 达托霉素高产菌株及制备方法 |
CN103421778A (zh) * | 2012-05-23 | 2013-12-04 | 中国科学院微生物研究所 | 一种链霉菌组成型启动子及其应用 |
CN104513840B (zh) * | 2013-09-30 | 2018-09-18 | 上海医药工业研究院 | 一种提高聚酮类化合物发酵产量的方法 |
CN105779400A (zh) * | 2016-03-11 | 2016-07-20 | 中国药科大学 | 底物亲和力提高的脂肪酸amp连接酶突变体及其应用 |
CN107267434B (zh) * | 2017-08-08 | 2021-03-26 | 浙江大学 | 一种高产达托霉素的玫瑰孢链霉菌l31及其构建方法 |
CN113717909A (zh) * | 2020-05-26 | 2021-11-30 | 杭州中美华东制药有限公司 | 一种达托霉素高产菌株及其应用 |
CN113717259A (zh) * | 2020-05-26 | 2021-11-30 | 浙江工业大学 | 一种玫瑰孢链霉菌中提高癸酸利用率及耐受度的调控基因及应用 |
-
2010
- 2010-07-26 CN CN 201010236729 patent/CN102146414B/zh not_active Expired - Fee Related
Non-Patent Citations (3)
Title |
---|
Vivian Miao等.Daptomycin biosynthesis in Streptomyces reseosporus: cloning and analysis of the gene cluster and revision of peptide stereochemistry.《Microbiology》.2005,第151卷1507-1523. * |
刘伯宁等.达托霉素生产工艺及其衍生物组合生物合成.《中国生物工程杂志》.2010,第30卷(第3期),119-124. * |
周剑等.氮离子注入玫瑰孢链霉菌选育达托霉素高产菌株的研究.《辐射研究与辐射工艺学报》.2008,第26卷(第5期),317-320. * |
Also Published As
Publication number | Publication date |
---|---|
CN102146414A (zh) | 2011-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102146414B (zh) | 玫瑰孢链霉菌基因工程菌的构建方法及其应用 | |
Liu et al. | Indole-3-acetic acid in Burkholderia pyrrocinia JK-SH007: Enzymatic identification of the indole-3-acetamide synthesis pathway | |
CN101948794A (zh) | 产植物类黄酮合成相关酶的工程乳酸菌及其构建和应用 | |
CN101613712B (zh) | 提高阿维菌素和/或伊维菌素产量的方法及生产菌株 | |
CN111454924B (zh) | 一种绿色木霉组蛋白乙酰化酶编码基因TvGCN5及其应用 | |
CN102191208A (zh) | 高产多杀菌素的基因工程菌及其制备方法 | |
CN106434702A (zh) | 一种帕克特酰胺的生物合成基因簇及其应用 | |
CN104762247A (zh) | 提高生产子囊霉素产量的基因工程菌株及构建方法 | |
CN101824452B (zh) | 玫瑰孢链霉菌高效生产达托霉素的分批式补料发酵方法 | |
KR20130091335A (ko) | 이소발레릴 스피라마이신 i을 생산하는 유전학적으로 공학처리된 균주 wsjia | |
CN111621454B (zh) | 基因工程高产菌株淀粉酶产色链霉菌及ε-聚赖氨酸的生产方法和应用 | |
CN109486688A (zh) | 一种里氏木霉基因工程菌及其制备方法和应用 | |
CN103834605B (zh) | 一种阿维菌素产生菌及其制备方法和应用 | |
CN110564718B (zh) | 高通量诱变筛选高产两性霉素b结节链霉菌的方法及菌株 | |
CN111197020A (zh) | 一种生产米尔贝霉素的重组菌及其构建方法与应用 | |
CN102260700B (zh) | 玫瑰孢链霉菌基因工程菌hp-orf53-55的构建方法及其应用 | |
CN113462628B (zh) | 一株产血红素的基因工程菌及其构建方法和应用 | |
CN109554321B (zh) | 一种高产脂肽的基因工程菌及其应用 | |
CN108998460B (zh) | 一种红景天苷的生物生产方法 | |
CN108467847B (zh) | 可胞外分泌菊粉内切酶的重组枯草芽孢杆菌及其制备方法和应用 | |
CN102286497A (zh) | 过表达zwf2基因提高达托霉素产量的方法及其应用 | |
CN107541503A (zh) | 一种甲基转移酶GenL和其编码基因genL及应用 | |
CN105524849A (zh) | 一株不依赖于甲硫氨酸的头孢菌素高产基因工程菌株的构建及其应用 | |
CN116286575B (zh) | 一种利用枯草芽孢杆菌高效表达生淀粉α-淀粉酶的方法 | |
CN114717281B (zh) | 通过优化碳源提升异源多杀菌素表达菌株发酵产量的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Wen Jianping Inventor after: Qi Haishan Inventor after: Yu Guanghai Inventor after: Jia Xiaoqiang Inventor before: Wen Jianping Inventor before: Yu Guanghai Inventor before: Jia Xiaoqiang |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WEN JIANPING YU GUANGHAI JIA XIAOQIANG TO: WEN JIANPING QI HAISHAN YU GUANGHAI JIA XIAOQIANG |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201130 Address after: 06-01-45, block B, Baoneng entrepreneurship center, Xiyuzhuang street, Hongqiao District, Tianjin Patentee after: Tianjin Kerun productivity promotion Co.,Ltd. Address before: 300072 Tianjin City, Nankai District Wei Jin Road No. 92, Tianjin University Patentee before: Tianjin University Effective date of registration: 20201130 Address after: Zilang Road, Chongchuan District 226000 Jiangsu city of Nantong province (No. 30 Langshan Industrial Park No. 6 Building 2 floor) Patentee after: JIANGSU YIKAI MEDICAL EQUIPMENT Co.,Ltd. Address before: 06-01-45, block B, Baoneng entrepreneurship center, Xiyuzhuang street, Hongqiao District, Tianjin Patentee before: Tianjin Kerun productivity promotion Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121212 |